Mounjaro Cost in 2026: List Price, Coverage, and Savings

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Mounjaro (tirzepatide) sits near the top of GLP-1 search interest in the U.S. as of April 2026, and the cost question rarely has a single clean answer. This article breaks down the published list price, the coverage rules that reshape it, the savings routes patients actually use, and where compounded formulations fit — everything reported as published as of April 2026, not as a guarantee.

The published list price

Mounjaro’s list price is approximately $1,069 per month at U.S. list as of April 2026 (Eli Lilly published pricing). That number is the starting line, not the finish — it precedes insurance, rebates, savings cards, and pharmacy pricing. Most insured patients never pay the sticker.

Why coverage is the biggest swing factor

Whether insurance applies depends on the plan formulary and the FDA-approved indication on the prescription. Many commercial plans cover tirzepatide for type 2 diabetes, while coverage for chronic weight management is more variable and frequently gated behind prior authorization or BMI criteria. Confirm your own plan’s rules directly as of April 2026.

Savings cards and pharmacy discounts

Eli Lilly publishes a manufacturer savings-card program that can meaningfully lower monthly out-of-pocket cost for eligible commercially-insured patients. Independent discount platforms such as GoodRx and SingleCare list coupon prices that vary by pharmacy. Eligibility and amounts change, so verify on the manufacturer site or with your pharmacy at the time of fill.

Where compounded formulations fit

The FDA listed tirzepatide on its drug shortage list between 2022 and 2024, which opened a pathway for licensed 503A compounding pharmacies to prepare tirzepatide formulations. The FDA resolved that shortage in 2024, narrowing but not closing the pathway. Legitimate compounded protocols prescribed by a licensed clinician through a state-licensed pharmacy remain an option, though pricing and access vary.

Cash-pay versus insured pricing

Two very different cost pictures sit behind the same drug. For insured patients whose plan covers the written indication, the meaningful number is a copay shaped by the formulary tier and any savings card. For cash-pay patients — those without coverage for the indication — the number is closer to list price, softened only by whatever coupon applies. Compounded-pharmacy protocols form a third, separate track priced independently of the brand. Knowing which bucket you fall into is the first step to reading any Mounjaro price quote accurately.

The PlexusDx protocols and pricing

PlexusDx offers clinician-supervised compounded GLP-1 protocols inside its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared. Current pricing for each is published on its product page as of April 2026.

Before any cost decision, the biology deserves a look. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, GLP1R, and MC4R variants that shape baseline GLP-1, appetite-regulation, and energy-balance biology. That genetic context is the test before you invest framing PlexusDx brings to every protocol conversation.

Disclaimer: This article is educational. PlexusDx offers tirzepatide through its Weight Management Protocols — this article covers the mechanism, evidence, and genetic context that informs any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Learn more about the PlexusDx Tirzepatide protocol or the oral tirzepatide protocol inside the Weight Management Protocols collection, or start upstream and take the Precision Peptide Genetic Test first.

Frequently Asked Questions

What actually drives Mounjaro’s cost?

The starting point is a list price of about $1,069 per month at U.S. list as of April 2026 (Eli Lilly published pricing). From there, insurance coverage, the FDA indication on the prescription, savings-card eligibility, and pharmacy choice determine what you pay. List price is rarely the final number for insured patients.

Can insurance bring the cost down?

Often, yes — but it depends on the plan. Many commercial plans cover tirzepatide for type 2 diabetes, while weight-management coverage is more variable and frequently requires prior authorization or BMI-based criteria. The indication written on the prescription and the plan formulary largely decide the out-of-pocket total.

Are compounded formulations a lower-cost route?

Compounded tirzepatide from licensed 503A pharmacies has historically been priced below Mounjaro’s list price. The trade-offs are regulatory complexity, variability in prescriber oversight, and the FDA’s evolving stance after the 2024 shortage resolution. Compounded products are not identical to the brand and should be discussed with a qualified clinician.

Does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

It does not predict response to Mounjaro or any specific medication. It analyzes pathway-level variants in FTO, and MC4R that shape baseline GLP-1 and energy-balance biology — the upstream context that applies across every GLP-1 pathway compound, independent of what any protocol costs.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education